MiR-132 Inhibits Expression of SIRT1 and Induces Pro-inflammatory Processes of Vascular Endothelial Inflammation through Blockade of the SREBP-1c Metabolic Pathway

Overview of attention for article published in Cardiovascular Drugs and Therapy, June 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 57 Dimensions

Readers on

mendeley: 50 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Downregulating miR-132 for the treatment of lipid related disorders

Grant US-10174320-B2

United States of America

DOWNREGULATING MIR-132 FOR THE TREATMENT OF LIPID RELATED DISORDERS

Application WO-2016042561-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.